【Moderna股价涨超176%，昆仑资本mRNA肿瘤项目迎价值重估】近日，Moderna股价盘中暴涨超176%，市值突破696亿美元，带动默沙东跟涨超12%。引发资本追捧的，是Moderna与默沙东联合宣布的III期INTerpath-001试验阳性结果——个体化mRNA新抗原疫苗联合Keytruda，显著降低黑色素瘤患者复发和远处转移风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.